3 new shares of science and technology board are about to be issued (attached)

Your location: >> The new shares of the 3 science and technology board will be issued soon (attached). According to the issuance arrangement, the three new shares of the science and technology board will be issued soon. On March 11, the first medicine control was issued on March 14;

The upcoming three new shares are expected to raise 100 million yuan. He Yuan Bio, the issuance date is March 11, the purchase code is 78,7238. It is planned to disclose 100 million shares of shares. It is expected to raise 100 million yuan, of which 10,000 shares are issued online. The issuer is a biotechnology company focusing on the field of gene therapy, focusing on genetic therapy carrier research and development of genetic treatment carrier carrier research and development of genetic treatment carrier, target and efficacy for reorganized virus carrier products, tumache virus products, CAR-T products and other gene therapy. Research, process development and testing, IND-CMC pharmacy research, clinical I-III phase and commercial GMP production and other integrated CRO/CDMO services.

The industry is the research and test development industry. In 2020 and 2021, the net profit was 10,000 yuan and 10,000 yuan, respectively, and the year-on-year change was%and-%. Junpu Intelligent, the issuance date is March 11, the purchase code is 78,7306. It is planned to publicize 100 million shares of shares. It is expected to raise 100 million yuan. Among them, 10,000 shares are issued online.

The company is a globalized intelligent manufacturing equipment supplier. It is mainly engaged in the development, production, sales and services of intelligent manufacturing equipment and digital software, and for the development, production, sales and services of intelligent manufacturing equipment and digital software. Well -known manufacturers provide overall industrial intelligent manufacturing solutions. The industry is a dedicated equipment manufacturing industry. In 2020 and 2021, the net profit was -1 million yuan and 10,000 yuan, respectively, a year-on-year change range of-%and%. The first medicine holding date is March 14, and the purchase code is 78,7197. It is planned to disclose 10,000 shares of shares. It is expected to raise 100 million yuan, of which 10,000 shares are issued online.

The company is a small molecular innovation pharmaceutical company in the clinical research stage. The R & D pipeline covers key tumor indications such as non -small cell lung cancer, lymphoma, hepatocytal carcinoma, pancreatic cancer, thyroid cancer, ovarian cancer, leukemia, and II diabetes. Other important disease areas.

The industry is the pharmaceutical manufacturing industry. In 2020 and 2021, the net profit was-100 million yuan and-billion yuan, respectively, with a year-on-year change of-%and%. (Data Bao) List of new shares issuance form referred to as the total amount of the issuance of the purchase code of the purchase code (10,000 shares) online issuance (10,000 shares) purchase price (yuan) purchase limit (10,000 yuan) required for the upper limit : This article is a news report that it does not constitute investment suggestions. The stock market has risks, and investment needs to be cautious.